134 related articles for article (PubMed ID: 33237539)
1. Isolation of Human Circulating Myeloid-Derived Suppressor Cells and Analysis of Their Immunosuppressive Activity.
Bruderek K; Schirrmann R; Brandau S
Methods Mol Biol; 2021; 2236():43-56. PubMed ID: 33237539
[TBL] [Abstract][Full Text] [Related]
2. Protocol to assess the suppression of T-cell proliferation by human MDSC.
Bruger AM; Vanhaver C; Bruderek K; Amodio G; Tavukçuoğlu E; Esendagli G; Gregori S; Brandau S; van der Bruggen P
Methods Enzymol; 2020; 632():155-192. PubMed ID: 32000895
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotyping of Circulating Myeloid-Derived Suppressor Cells (MDSC) in the Peripheral Blood of Cancer Patients.
Bruderek K; Schirrmann R; Brandau S
Methods Mol Biol; 2021; 2236():1-7. PubMed ID: 33237535
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Generation of Human Neutrophilic Myeloid-Derived Suppressor Cells.
Singh A; Rieber N
Methods Mol Biol; 2021; 2236():77-83. PubMed ID: 33237542
[TBL] [Abstract][Full Text] [Related]
5. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.
Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S
Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893
[No Abstract] [Full Text] [Related]
6. Isolation and Functional Characterization of Myeloid-Derived Suppressor Cells in Infections Under High Containment.
Kotze LA; Leukes VN; Du Plessis N
Methods Mol Biol; 2021; 2236():129-156. PubMed ID: 33237546
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Generation of Murine Myeloid-Derived Suppressor Cells, Analysis of Markers, Developmental Commitment, and Function.
Eckert I; Ribechini E; Lutz MB
Methods Mol Biol; 2021; 2236():99-114. PubMed ID: 33237544
[TBL] [Abstract][Full Text] [Related]
8. Avoiding phagocytosis-related artifact in myeloid derived suppressor cell T-lymphocyte suppression assays.
Davis RJ; Silvin C; Allen CT
J Immunol Methods; 2017 Jan; 440():12-18. PubMed ID: 27856191
[TBL] [Abstract][Full Text] [Related]
9. Human neutrophils can mimic myeloid-derived suppressor cells (PMN-MDSC) and suppress microbead or lectin-induced T cell proliferation through artefactual mechanisms.
Negorev D; Beier UH; Zhang T; Quatromoni JG; Bhojnagarwala P; Albelda SM; Singhal S; Eruslanov E; Lohoff FW; Levine MH; Diamond JM; Christie JD; Hancock WW; Akimova T
Sci Rep; 2018 Feb; 8(1):3135. PubMed ID: 29453429
[TBL] [Abstract][Full Text] [Related]
10. Neutrophils as Suppressors of T Cell Proliferation: Does Age Matter?
Aarts CEM; Hiemstra IH; Tool ATJ; van den Berg TK; Mul E; van Bruggen R; Kuijpers TW
Front Immunol; 2019; 10():2144. PubMed ID: 31572368
[TBL] [Abstract][Full Text] [Related]
11. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
[TBL] [Abstract][Full Text] [Related]
12. Functional Assays Evaluating Immunosuppression Mediated by Myeloid-Derived Suppressor Cells.
Reuven O; Mikula I; Ashkenazi-Preiser H; Twaik N; Ben-Meir K; Meirow Y; Daniel L; Kariv G; Kurd M; Baniyash M
Curr Protoc; 2022 Oct; 2(10):e557. PubMed ID: 36282094
[TBL] [Abstract][Full Text] [Related]
13. The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function.
Du J; Sun X; Song Y
Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):62-67. PubMed ID: 28466815
[TBL] [Abstract][Full Text] [Related]
14. Detection of Circulating and Tissue Myeloid-Derived Suppressor Cells (MDSC) by Flow Cytometry.
Sanchez-Pino MD
Methods Mol Biol; 2022; 2422():247-261. PubMed ID: 34859411
[TBL] [Abstract][Full Text] [Related]
15. Measuring Suppressive Activity and Autophagy in Myeloid-Derived Suppressor Cells.
Papaioannou AS; Boumpas A; Papadopoulou M; Hatzioannou A; Alissafi T; Verginis P
Methods Mol Biol; 2021; 2236():85-98. PubMed ID: 33237543
[TBL] [Abstract][Full Text] [Related]
16. T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells.
Azzaoui I; Uhel F; Rossille D; Pangault C; Dulong J; Le Priol J; Lamy T; Houot R; Le Gouill S; Cartron G; Godmer P; Bouabdallah K; Milpied N; Damaj G; Tarte K; Fest T; Roussel M
Blood; 2016 Aug; 128(8):1081-92. PubMed ID: 27338100
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Suppression of CD4
Vlachou K; Verginis P
Methods Mol Biol; 2019; 1899():119-128. PubMed ID: 30649769
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis.
Fernandez IE; Greiffo FR; Frankenberger M; Bandres J; Heinzelmann K; Neurohr C; Hatz R; Hartl D; Behr J; Eickelberg O
Eur Respir J; 2016 Oct; 48(4):1171-1183. PubMed ID: 27587556
[TBL] [Abstract][Full Text] [Related]
19. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative.
Karin N
Front Immunol; 2020; 11():557586. PubMed ID: 33193327
[TBL] [Abstract][Full Text] [Related]
20. Preliminary assessment of the feasibility of autologous myeloid-derived suppressor cell infusion in non-human primate kidney transplantation.
Ezzelarab MB; Perez-Gutierrez A; Humar A; Wijkstrom M; Zahorchak AF; Lu-Casto L; Wang YC; Wiseman RW; Minervini M; Thomson AW
Transpl Immunol; 2019 Oct; 56():101225. PubMed ID: 31330261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
